サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1788282

患者制御鎮痛ポンプの世界市場

Patient-Controlled Analgesic Pumps

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
患者制御鎮痛ポンプの世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

患者制御鎮痛ポンプの世界市場は2030年までに6億8,690万米ドルに達する見込み

2024年に5億590万米ドルと推定される患者制御鎮痛ポンプの世界市場は、2024年から2030年にかけてCAGR 5.2%で成長し、2030年には6億8,690万米ドルに達すると予測されます。本レポートで分析しているセグメントの1つであるエレクトロニクスは、CAGR 4.5%を記録し、分析期間終了時には4億5,560万米ドルに達すると予測されています。メカニカルセグメントの成長率は、分析期間中CAGR 6.9％と推定されます。

米国市場は1億3,300万米ドルと推定、中国はCAGR 5.1％で成長予測

米国の患者制御鎮痛ポンプ市場は、2024年に1億3,300万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを5.1%として、2030年までに1億1,040万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.5％と4.6％と予測されています。欧州では、ドイツがCAGR 4.3%で成長すると予測されています。

世界の患者制御鎮痛ポンプ市場- 主要動向と促進要因まとめ

疼痛管理は新時代へ？高まる患者制御鎮痛ポンプの採用

疼痛管理は現代のヘルスケアにおいて重要な焦点となっており、患者制御鎮痛（PCA）ポンプは疼痛緩和の投与方法に革命をもたらしています。PCAポンプは、オピオイドや局所麻酔薬などの鎮痛薬を、静脈内、硬膜外、皮下からコントロールしながら投与することで、患者が自ら疼痛を管理できるようにする装置です。PCAポンプは、手術後の回復、がんの疼痛管理、緩和ケアに広く使用されており、看護スタッフへの依存を減らしながら、個人に合わせた鎮痛を提供します。従来の疼痛管理方法とは異なり、PCAポンプはあらかじめ定義された安全限度内でオンデマンドの薬剤投与を可能にし、過剰投与や副作用のリスクを最小限に抑えます。慢性疼痛状態の有病率の増加、手術件数の増加、疼痛管理プロトコルの進歩が、病院、外来手術センター、在宅介護の各環境におけるPCAポンプの需要を促進しています。世界のオピオイド危機により処方薬の誤用が懸念される中、PCA技術は安全で効果的な疼痛管理を確実にするため、投与量制限機能、スマート薬物モニタリング、電子カルテ（EHR）統合を組み込むよう改良されています。ヘルスケアプロバイダーが患者中心のアプローチを優先する中、PCAポンプは疼痛管理を強化し、患者の満足度を向上させるための好ましいソリューションとして台頭してきています。

スマートテクノロジーはどのようにPCAポンプを強化しているのでしょうか？AI、ワイヤレスモニタリング、医薬品安全性イノベーション

スマートテクノロジーの統合はPCAポンプを変革し、より安全で、より効率的で、現代のヘルスケアシステムによりよく統合されています。先進的なPCAポンプは現在、ワイヤレス接続機能を備えており、医療提供者によるリアルタイムの遠隔モニタリングを可能にして、過剰投与事故を防ぎ、最適な疼痛管理を実現しています。患者の反応を分析し、オピオイドによる呼吸抑制の初期徴候を検出し、それに応じて投与パラメーターを調整するために、AIを搭載したアルゴリズムがPCA機器に組み込まれています。クローズドループ薬物送達システムやバーコードによる薬物確認などのドラッグデリバリーのイノベーションは、PCAポンプの精度をさらに高め、投薬ミスを減らし、病院の安全プロトコルの遵守を確実にしています。輸液分析を備えたスマートPCAポンプは、患者の使用パターンを追跡し、疼痛管理の最適化のための予測的洞察を提供することができます。病院EHRとの統合により、薬剤投与の自動文書化が可能になり、臨床ワークフローの効率と規制遵守が改善されます。経皮および経鼻ドラッグデリバリーシステムを含む非侵襲的PCA技術の開発もまた、患者に針を使わない疼痛緩和オプションを提供し、人気を集めています。デジタルヘルスエコシステムが進化するにつれ、AI、データ分析、コネクテッドデバイスの融合がPCAポンプの展望を再構築し、疼痛管理をより安全で効果的なものにしています。

PCAポンプはどこで使用されていますか？ヘルスケアにおける採用の拡大

PCAポンプは、病院、外来外科センター、緩和ケア、および在宅ヘルスケア環境における疼痛管理に不可欠な要素になりつつあります。病院では、PCAポンプは整形外科、心臓血管、腹部などの大手術後の急性疼痛を管理するために、術後回復室で広く使用されています。がん治療センターでは、患者ががんに関連した激しい疼痛を管理するためにPCA技術を活用しており、化学療法や緩和ケア中の継続的な緩和を確保しています。在宅ヘルスケアプロバイダーは、慢性疼痛を抱える患者が自宅で鎮痛をコントロールできるようにするため、ポータブルPCAポンプをますます導入しています。外来手術センターでは、PCA装置を当日の手術ケアプロトコールに統合し、効率的な鎮痛と回復時間の短縮を可能にしています。小児医療や老人医療の現場でもPCAポンプが採用されており、脆弱な患者集団のリスクを最小限に抑えるように設計された特別な安全機能を備えています。軍隊や外傷治療ユニットでは、戦場での負傷管理にPCA技術の使用を模索しており、遠隔地で負傷した兵士に迅速な疼痛緩和を提供しています。ヘルスケア施設が高度な疼痛管理ソリューションを採用し続けるにつれて、PCAポンプの需要は多様な医療環境で高まっています。

患者制御鎮痛ポンプ市場の成長はいくつかの要因に牽引されている...

世界の外科手術の発生率の上昇は、PCAポンプ市場の成長を促進する主な要因です。がん、関節炎、神経障害性疼痛などの慢性疼痛症状の有病率の増加は、高度疼痛管理ソリューションの需要を押し上げています。患者中心のケアモデルへのシフトは、ヘルスケアプロバイダーがPCAポンプを採用する原動力となっており、疼痛管理における患者の自律性を高めています。AIを活用したモニタリング、ワイヤレス接続、自動薬剤投与制御などの技術的進歩により、PCAポンプはより安全で効率的になっています。オピオイドの誤用や過剰摂取に対する懸念の高まりは、薬剤安全機能を強化したスマートPCAポンプの開発につながっています。在宅ヘルスケアと遠隔患者モニタリングの拡大は、携帯型およびウェアラブルPCAデバイスに新たな機会をもたらしています。安全な疼痛管理の実践とオピオイドスチュワードシッププログラムを促進する規制の義務化は、病院やヘルスケア機関におけるPCAポンプの採用を促進しています。デジタルヘルスインフラへの投資の増加は、PCAポンプと病院の電子カルテ（EHR）および臨床意思決定支援システムとのシームレスな統合を促進しています。医療機器メーカーと製薬会社の戦略的提携は、疼痛緩和技術の革新を促進しています。ヘルスケアシステムが精密医療とデータ主導の疼痛管理戦略に向けて進化を続ける中、患者制御鎮痛ポンプ市場は持続的な成長を遂げ、疼痛治療の未来を変えることになるでしょう。

セグメント

タイプ（電子式、機械式）、用途（糖尿病、オンコロジー、消化器病、血液学、その他）、最終用途（病院、専門クリニック、外来手術センター、在宅医療現場）

調査対象企業の例

  • Abbott Laboratories
  • Ace Medical
  • Arcomed AG
  • Avanos Medical, Inc.
  • Avante Health Solutions
  • B. Braun Medical Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company（BD）
  • Changzhou Medical Bioengineering Co., Ltd.
  • Fresenius SE & Co. KGaA
  • Henan Tuoren Medical Device Co., Ltd.
  • ICU Medical, Inc.
  • Medtronic plc
  • Micrel Medical Devices SA
  • Pfizer Inc.（Hospira）
  • Q-Core Medical Ltd.
  • SCW Medicath Ltd.
  • Smiths Medical（ICU Medical）
  • Terumo Corporation
  • Zhejiang Runqiang Medical Instruments

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP32496

Global Patient-Controlled Analgesic Pumps Market to Reach US$686.9 Million by 2030

The global market for Patient-Controlled Analgesic Pumps estimated at US$505.9 Million in the year 2024, is expected to reach US$686.9 Million by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Electronic, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$455.6 Million by the end of the analysis period. Growth in the Mechanical segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$133.0 Million While China is Forecast to Grow at 5.1% CAGR

The Patient-Controlled Analgesic Pumps market in the U.S. is estimated at US$133.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$110.4 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Patient-Controlled Analgesic Pumps Market - Key Trends & Drivers Summarized

Is Pain Management Entering a New Era? The Growing Adoption of Patient-Controlled Analgesic Pumps

Pain management has become a critical focus in modern healthcare, with patient-controlled analgesic (PCA) pumps revolutionizing the way pain relief is administered. These devices empower patients to manage their own pain by delivering controlled doses of analgesic medication, typically opioids or local anesthetics, through intravenous (IV), epidural, or subcutaneous routes. PCA pumps are widely used in post-surgical recovery, cancer pain management, and palliative care, offering personalized pain relief while reducing dependency on nursing staff. Unlike conventional pain management methods, PCA pumps allow for on-demand drug administration within predefined safety limits, minimizing the risk of overmedication and adverse effects. The increasing prevalence of chronic pain conditions, rising surgical volumes, and advancements in pain management protocols are driving the demand for PCA pumps across hospitals, ambulatory surgical centers, and home care settings. With the global opioid crisis raising concerns over prescription drug misuse, PCA technology is being refined to incorporate dose-limiting features, smart drug monitoring, and electronic health record (EHR) integration to ensure safe and effective pain management. As healthcare providers prioritize patient-centered approaches, PCA pumps are emerging as a preferred solution for enhancing pain control and improving patient satisfaction.

How Are Smart Technologies Enhancing PCA Pumps? AI, Wireless Monitoring & Drug Safety Innovations

The integration of smart technologies is transforming PCA pumps, making them safer, more efficient, and better integrated into modern healthcare systems. Advanced PCA pumps now feature wireless connectivity, allowing real-time remote monitoring by healthcare providers to prevent overdose incidents and ensure optimal pain management. AI-powered algorithms are being incorporated into PCA devices to analyze patient responses, detect early signs of opioid-induced respiratory depression, and adjust dosage parameters accordingly. Drug safety innovations such as closed-loop drug delivery systems and barcode medication verification are further enhancing the accuracy of PCA pumps, reducing medication errors, and ensuring compliance with hospital safety protocols. Smart PCA pumps equipped with infusion analytics can track patient usage patterns and provide predictive insights for pain management optimization. Integration with hospital EHRs enables automated documentation of drug administration, improving clinical workflow efficiency and regulatory compliance. The development of non-invasive PCA technologies, including transdermal and intranasal drug delivery systems, is also gaining traction, offering patients needle-free pain relief options. As digital health ecosystems evolve, the convergence of AI, data analytics, and connected devices is reshaping the PCA pump landscape, making pain management safer and more effective.

Where Are PCA Pumps Being Used? Expanding Adoption Across Healthcare Settings

PCA pumps are becoming an essential component of pain management in hospitals, outpatient surgical centers, palliative care, and home healthcare settings. In hospitals, PCA pumps are widely used in post-operative recovery units to manage acute pain following major surgeries such as orthopedic, cardiovascular, and abdominal procedures. Cancer treatment centers are leveraging PCA technology to help patients manage severe cancer-related pain, ensuring continuous relief during chemotherapy and palliative care. Home healthcare providers are increasingly deploying portable PCA pumps to allow patients with chronic pain conditions to receive controlled analgesia in a home setting, reducing hospital visits and improving quality of life. Ambulatory surgical centers are integrating PCA devices into same-day surgical care protocols, enabling efficient pain relief with faster recovery times. Pediatric and geriatric care settings are also adopting PCA pumps, with specialized safety features designed to minimize risks in vulnerable patient populations. Military and trauma care units are exploring the use of PCA technology for battlefield injury management, providing rapid pain relief to injured soldiers in remote locations. As healthcare facilities continue to embrace advanced pain management solutions, the demand for PCA pumps is growing across diverse medical environments.

The Growth in the Patient-Controlled Analgesic Pumps Market Is Driven by Several Factors…

The rising incidence of surgical procedures worldwide is a key driver fueling the growth of the PCA pump market. The increasing prevalence of chronic pain conditions such as cancer, arthritis, and neuropathic pain is boosting demand for advanced pain management solutions. The shift toward patient-centric care models is driving healthcare providers to adopt PCA pumps, enhancing patient autonomy in pain management. Technological advancements, including AI-powered monitoring, wireless connectivity, and automated drug dose control, are making PCA pumps safer and more efficient. The rising concerns over opioid misuse and overdose are leading to the development of smart PCA pumps with enhanced drug safety features. The expansion of home healthcare and remote patient monitoring is creating new opportunities for portable and wearable PCA devices. Regulatory mandates promoting safe pain management practices and opioid stewardship programs are encouraging the adoption of PCA pumps in hospitals and healthcare institutions. The increasing investment in digital health infrastructure is facilitating seamless integration of PCA pumps with hospital electronic health records (EHRs) and clinical decision support systems. Strategic collaborations between medical device manufacturers and pharmaceutical companies are driving innovations in pain relief technologies. As healthcare systems continue to evolve toward precision medicine and data-driven pain management strategies, the patient-controlled analgesic pump market is set for sustained growth, transforming the future of pain therapy.

SCOPE OF STUDY:

The report analyzes the Patient-Controlled Analgesic Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Electronic, Mechanical); Application (Diabetes, Oncology, Gastroenterology, Hematology, Others); End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Home Care Settings)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • Ace Medical
  • Arcomed AG
  • Avanos Medical, Inc.
  • Avante Health Solutions
  • B. Braun Medical Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Changzhou Medical Bioengineering Co., Ltd.
  • Fresenius SE & Co. KGaA
  • Henan Tuoren Medical Device Co., Ltd.
  • ICU Medical, Inc.
  • Medtronic plc
  • Micrel Medical Devices SA
  • Pfizer Inc. (Hospira)
  • Q-Core Medical Ltd.
  • SCW Medicath Ltd.
  • Smiths Medical (ICU Medical)
  • Terumo Corporation
  • Zhejiang Runqiang Medical Instruments

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Patient-Controlled Analgesic Pumps - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Post-Surgical Pain Management Protocols Accelerates Demand for Patient-Controlled Analgesic Pumps
    • Focus on Personalized Pain Therapy Drives Adoption of PCA Devices
    • Growth in Ambulatory Surgical Centers Expands Use of Portable Analgesic Pumps
    • Integration with Digital Health Records Strengthens Monitoring and Control Capabilities
    • Rising Opioid Safety Concerns Throw the Spotlight on Controlled Drug Delivery Solutions
    • Demand for Non-Invasive Pain Management Spurs Innovation in Pump-Based Therapies
    • Increasing Patient Preference for Self-Managed Pain Relief Drives PCA Device Utilization
    • AI-Enhanced Dosage Monitoring Improves Accuracy and Minimizes Overdose Risk
    • Regulatory Scrutiny on Drug Delivery Devices Spurs Development of Tamper-Resistant Pumps
    • Hospital Efforts to Reduce Nursing Workload Strengthen Use of Automated PCA Systems
    • Expansion of Home Recovery Programs Supports Demand for Compact, User-Friendly Pumps
    • Growth in Pediatric and Geriatric Surgery Volumes Creates Niche PCA Product Demand
    • Clinical Trials Supporting Efficacy Drive Confidence and Market Acceptance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Patient-Controlled Analgesic Pumps Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Patient-Controlled Analgesic Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Electronic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Electronic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Mechanical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Mechanical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • JAPAN
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • CHINA
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • EUROPE
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • FRANCE
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • GERMANY
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • UNITED KINGDOM
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030

IV. COMPETITION